SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-003716
Filing Date
2015-11-16
Accepted
2015-11-13 19:50:44
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vsta10q_sep302015.htm 10-Q 1709248
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31-1.htm EX-31.1 9660
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31-2.htm EX-31.2 12669
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS REQUIRED BY RULE ex32.htm EX-32 6140
  Complete submission text file 0001415889-15-003716.txt   5565745

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vsta-20150930.xml EX-101.INS 1069108
6 XBRL TAXONOMY EXTENSION SCHEMA vsta-20150930.xsd EX-101.SCH 45022
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsta-20150930_cal.xml EX-101.CAL 45685
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsta-20150930_def.xml EX-101.DEF 224663
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsta-20150930_lab.xml EX-101.LAB 253345
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsta-20150930_pre.xml EX-101.PRE 272296
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 151230746
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences